Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

References for PMC Articles for PubMed (Select 17921041)

1.

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

Boddaert N, Le Quan Sang KH, Rötig A, Leroy-Willig A, Gallet S, Brunelle F, Sidi D, Thalabard JC, Munnich A, Cabantchik ZI.

Blood. 2007 Jul 1;110(1):401-8. Epub 2007 Mar 22.

2.

Gene therapy for ocular neovascularization.

Campochiaro PA.

Curr Gene Ther. 2007 Feb;7(1):25-33. Review.

PMID:
17305526
3.

Catastrophic visual loss in a patient with Friedreich ataxia.

Porter N, Downes SM, Fratter C, Anslow P, Németh AH.

Arch Ophthalmol. 2007 Feb;125(2):273-4. No abstract available.

PMID:
17296906
4.

Differential sensitivity of cones to iron-mediated oxidative damage.

Rogers BS, Symons RC, Komeima K, Shen J, Xiao W, Swaim ME, Gong YY, Kachi S, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2007 Jan;48(1):438-45.

PMID:
17197565
5.

Iron levels in human retina: sex difference and increase with age.

Hahn P, Ying GS, Beard J, Dunaief JL.

Neuroreport. 2006 Nov 27;17(17):1803-6.

PMID:
17164668
6.

Brain iron metabolism.

Rouault TA, Cooperman S.

Semin Pediatr Neurol. 2006 Sep;13(3):142-8. Review.

PMID:
17101452
7.
8.

Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium.

Martin PM, Gnana-Prakasam JP, Roon P, Smith RG, Smith SB, Ganapathy V.

Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4238-44.

PMID:
17003411
9.

NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1.

Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE 3rd, Papadopoulos V, Snyder SH.

Neuron. 2006 Aug 17;51(4):431-40.

10.

Hereditary hemochromatosis.

Pietrangelo A.

Biochim Biophys Acta. 2006 Jul;1763(7):700-10. Epub 2006 May 27. Review.

11.

Regulation of iron metabolism by hepcidin.

Nemeth E, Ganz T.

Annu Rev Nutr. 2006;26:323-42. Review.

PMID:
16848710
12.
13.

Deferasirox--an oral agent for chronic iron overload.

Vanorden HE, Hagemann TM.

Ann Pharmacother. 2006 Jun;40(6):1110-7. Epub 2006 May 30. Review.

PMID:
16735647
14.

The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.

Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, Gunatilaka TL, Medeiros NE, Presley JB, Campochiaro PA, Curcio CA, Dunaief JL, Zack DJ.

Invest Ophthalmol Vis Sci. 2006 May;47(5):2135-40.

PMID:
16639025
15.

The evolution of iron chelators for the treatment of iron overload disease and cancer.

Kalinowski DS, Richardson DR.

Pharmacol Rev. 2005 Dec;57(4):547-83. Review.

16.

Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration.

Dentchev T, Hahn P, Dunaief JL.

Arch Ophthalmol. 2005 Dec;123(12):1745-6. No abstract available.

PMID:
16344450
17.

Non-HFE hemochromatosis.

Pietrangelo A.

Semin Liver Dis. 2005 Nov;25(4):450-60. Review.

PMID:
16315138
18.

RPE65 is the isomerohydrolase in the retinoid visual cycle.

Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12413-8. Epub 2005 Aug 22.

19.

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC.

Cell Metab. 2005 Mar;1(3):191-200.

20.

SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.

Simůnek T, Boer C, Bouwman RA, Vlasblom R, Versteilen AM, Sterba M, Gersl V, Hrdina R, Ponka P, de Lange JJ, Paulus WJ, Musters RJ.

J Mol Cell Cardiol. 2005 Aug;39(2):345-54.

PMID:
15978614
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk